Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Hoskin

Showing results (41-50 of 241) with videos related to

Pageof 25
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 13, 2026
Limitations and future directions in identifying risk factors for radiotherapy related pelvic insufficiency fractures in gynecological cancers: A scoping reviewArtemis Bouzaki, Peter Hoskin, Claire E Higham, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2008
A Phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancerCarie Corner, Ana Maria Rojas, Linda Bryant, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2014
Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment techniqueLouise Murray, Ann Henry, Peter Hoskin, et al.
Radiation Oncology (London, England)|July 10, 2013
Second primary cancers after radiation for prostate cancer: a review of data from planning studiesLouise Murray, Ann Henry, Peter Hoskin, et al.
World Journal of Urology|April 4, 2024
Beyond surgery: bladder preservation and the role of systemic treatment in localised muscle-invasive bladder cancerMartin Swinton, Aarani Devi, Yee Pei Song, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 1, 2021
Impact of hypoxia on cervical cancer outcomesAnubhav Datta, Catharine West, James P B O'Connor, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 20, 2026
Long-term outcomes from a multicentre study of HDR monotherapy with a single fraction of 19 Gy for localized prostate cancerWiwatchai Sittiwong, Anna Lydon, James Wylie, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 13, 2024
Development and refinement of patient care recommendations in brachytherapy for locally advanced cervical cancer using nominal group technique workshopsPauline Humphrey, Emma Dures, Peter Hoskin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 10, 2026
Corrigendum to "Long-term outcomes from a multicentre study of HDR monotherapy with a single fraction of 19 Gy for localized prostate cancer" [Radiother. Oncol. 216 (2026) 111385]Wiwatchai Sittiwong, Anna Lydon, James Wylie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 2, 2017
Single-dose high-dose-rate brachytherapy compared to two and three fractions for locally advanced prostate cancerPeter Hoskin, Ana Rojas, Peter Ostler, et al.
Pageof 25

Showing results (41-50 of 241) with videos related to

Sort By:
Pageof 25
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 13, 2026
Limitations and future directions in identifying risk factors for radiotherapy related pelvic insufficiency fractures in gynecological cancers: A scoping reviewArtemis Bouzaki, Peter Hoskin, Claire E Higham, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2008
A Phase II study of high-dose-rate afterloading brachytherapy as monotherapy for the treatment of localized prostate cancerCarie Corner, Ana Maria Rojas, Linda Bryant, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 4, 2014
Second primary cancers after radiation for prostate cancer: a systematic review of the clinical data and impact of treatment techniqueLouise Murray, Ann Henry, Peter Hoskin, et al.
Radiation Oncology (London, England)|July 10, 2013
Second primary cancers after radiation for prostate cancer: a review of data from planning studiesLouise Murray, Ann Henry, Peter Hoskin, et al.
World Journal of Urology|April 4, 2024
Beyond surgery: bladder preservation and the role of systemic treatment in localised muscle-invasive bladder cancerMartin Swinton, Aarani Devi, Yee Pei Song, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 1, 2021
Impact of hypoxia on cervical cancer outcomesAnubhav Datta, Catharine West, James P B O'Connor, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 20, 2026
Long-term outcomes from a multicentre study of HDR monotherapy with a single fraction of 19 Gy for localized prostate cancerWiwatchai Sittiwong, Anna Lydon, James Wylie, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 13, 2024
Development and refinement of patient care recommendations in brachytherapy for locally advanced cervical cancer using nominal group technique workshopsPauline Humphrey, Emma Dures, Peter Hoskin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 10, 2026
Corrigendum to "Long-term outcomes from a multicentre study of HDR monotherapy with a single fraction of 19 Gy for localized prostate cancer" [Radiother. Oncol. 216 (2026) 111385]Wiwatchai Sittiwong, Anna Lydon, James Wylie, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 2, 2017
Single-dose high-dose-rate brachytherapy compared to two and three fractions for locally advanced prostate cancerPeter Hoskin, Ana Rojas, Peter Ostler, et al.
Pageof 25